 Language

PRODUCTS

PRODUCTS 



Respiratory Infectious Diseases IVD Products

Respiratory Infectious Diseases IVD

COVID-19 SOLUTIONs

COVID-19 IgG/IgM Rapid Test P2002

COVID-19 IgG/IgM Rapid Test P2004

GenSure™ COVID-19 Antigen Rapid Test Kit P2004s

COVID-19 Neutralizing Antibody Test(Fluorescence) P2005

COVID-19 Neutralizing Antibody Test(Latex) P2006

COVID-19/Flu A+B Antigen Combo Rapid Test P2007

SARS-CoV-2 N / S IgG Combo Rapid Test P2010

Monkeypox Virus Solutions

GenSure™ Monkeypox Virus(MPXV) IgM/IgG Antibody Rapid Test P2044

GenSure™ Monkeypox Virus(MPXV) Antigen Rapid Test P2046

QUALITATIVE RAPID TEST

Infectious Diseases

Drugs of Abuse

Fertility and Pregnancy

Cardiovascular Disease

Tumor Marker

Saliva Drugs Screen

QUANTITATIVE RAPID TEST

Inflammation

Cardiac Marker

Fertility and Pregnancy

Bone Metabolism

Anemia

Gastric Function

Renal Function

Thyroid Function

Glucose Metabolism

OTHER PRODUCTS

Methamphetamine (MET) Rapid Test Cassette

Morphine (MOP)

GENSURE BROCHURE

1/1

Number of views:

1000

A Participant of COVID-19 Prevention and Control Emergency Research Project of Shijiazhuang Science and Technology Bureau

Retail price

0.0

元

Market price

0.0

元

Number of views:

1000

Category：

Certificates

Quantity

Stock:



Hotline:+86-10-56370138

Inquiry

Related Products

Product Description

A Participant of COVID-19 Prevention and Control Emergency Research Project of Shijiazhuang Science and Technology Bureau – R&D of COVID-19 IgM Antibody Immunofluorescence Assay Test Kits

A Participant of a Key R&D project of the Science and Technology Department of Hebei Province

Regulatory Approval & Validation Worldwide

COVID-19 IgG/IgM Rapid Test P2002

This product is used for the qualitative testing of novel coronavirus (2019-nCoV) IgM and IgG antibodies in human serum, plasma or whole blood in vitro, and can be used for clinical auxiliary diagnosis of novel coronavirus (2019-nCoV) infection. The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

COVID-19 IgG/IgM Rapid Test P2004

The GenSure™ COVID-19 Antigen Rapid Test Kit is a rapid direct binding test for the visual detection of SARS-CoV-2 antigen in human nasal swab specimens as an aid in the diagnosis of SARS-CoV-2 infection.

GenSure™ COVID-19 Antigen Rapid Test Kit P2004s

The GenSure™ COVID-19 Antigen Rapid Test Kit is a polymer immunochromatographic technology and double antibody sandwich principle that is intended for the qualitative detection of the N protein antigen from SARS-CoV-2 in human nasal swab specimens directly. Testing is limited to laboratories and medical institutions.

COVID-19 Neutralizing Antibody Test(Fluorescence) P2005

The GenSure™ COVID-19 19 Neutralizing Antibody Test (Fluorescence) is for in vitro qualitative detection of the neutralizing antibodies against SARS-CoV-2 in human serum, plasma or whole blood.

COVID-19 Neutralizing Antibody Test(Latex) P2006

The GenSure™ COVID-19 Neutralizing Antibody Rapid Test (Latex) is a lateral flow assay intended for the qualitative detection of RBD antibody to SARS-CoV-2 in human serum, plasma or whole blood in vitro.

COVID-19/Flu A+B Antigen Combo Rapid Test P2007

The COVID-19/Flu A/B Antigen Combo Rapid Test is an in vitro rapid diagnostic immunochromatographic assay intended for the simultaneous qualitative detection and differentiation of the antigens from novel coronavirus, influenza A and influenza B in direct nasal swab specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. Clinical signs and symptoms of respiratory viral infection due to novel coronavirus and influenza can be similar. It is not intended to detect influenza C.

SARS-CoV-2 N / S IgG Combo Rapid Test P2010

The SARS-CoV-2 N / S IgG Combo Rapid Test is used for the qualitative testing of SARS-CoV-2 IgG antibody to nucleocapsid (N) and spike (S) protein in human serum, plasma or whole blood in vitro. It is used to assist in the diagnosis of SARS-CoV-2 infection and to detect whether the SARS-CoV-2 IgG antibody to N / S protein is generated in the blood after injected with the vaccine.

Rapid Tests for Pets

Kidney Function Test





ONLINE INQUIRY

Username used for comment:

客户留言

Description:

* Message contents：

Name：

Gender：

male

female

* Mobile phone：

Telephone：

* E-mail：

Address：

CONTACT INFORMATION

+86-10-56370138

Tel:400 007 9938

Email:info@gensbio.com
Web:www.gensbio.com
Add:3/F, Block 1, Boyun Building No. 9 Fengchan Rd Economic-Tech Development Zone,Shijiazhuang 050000, Hebei, P. R. China.